Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Ductal adenocarcinoma of pancreas
ADR ID BADD_A09826
ADR Hierarchy
07      Gastrointestinal disorders
07.21      Malignant and unspecified neoplasms gastrointestinal NEC
07.21.09      Pancreatic neoplasms
07.21.09.011      Ductal adenocarcinoma of pancreas
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.13      Gastrointestinal neoplasms malignant and unspecified
16.13.10      Pancreatic neoplasms malignant (excl islet cell and carcinoid)
16.13.10.006      Ductal adenocarcinoma of pancreas
Description Not Available
MedDRA Code 10073364
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Carcinoma obstructing pancreatic duct | Malignant neoplasm of pancreatic duct | Malignant neoplasm of pancreatic duct metastatic | Malignant neoplasm of pancreatic duct non-resectable | Malignant neoplasm of pancreatic duct recurrent | Malignant neoplasm of pancreatic duct resectable | Ductal adenocarcinoma of pancreas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00914Fludarabine0.000112%
BADD_D01633Oxaliplatin0.000224%
BADD_D01653Paclitaxel0.000112%
BADD_D01913Ranitidine0.000025%
The 1th Page    1    Total 1 Pages